Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Argus Health
Novartis
Baxter
Medtronic
AstraZeneca
Johnson and Johnson
Teva
US Army
Accenture

Generated: October 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020692

« Back to Dashboard
NDA 020692 describes SEREVENT, which is a drug marketed by Glaxosmithkline and is included in two NDAs. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the SEREVENT profile page.

The generic ingredient in SEREVENT is salmeterol xinafoate. There are eighteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the salmeterol xinafoate profile page.

Summary for NDA: 020692

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 020692

Mechanism of ActionAdrenergic beta2-Agonists

Suppliers and Packaging for NDA: 020692

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SEREVENT
salmeterol xinafoate
POWDER;INHALATION 020692 NDA GlaxoSmithKline LLC 0173-0520 0173-0520-00 1 INHALER in 1 CARTON (0173-0520-00) > 28 POWDER, METERED in 1 INHALER
SEREVENT
salmeterol xinafoate
POWDER;INHALATION 020692 NDA GlaxoSmithKline LLC 0173-0521 0173-0521-00 1 INHALER in 1 CARTON (0173-0521-00) > 60 POWDER, METERED in 1 INHALER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;INHALATIONStrengthEQ 0.05MG BASE/INH
Approval Date:Sep 19, 1997TE:RLD:Yes
Patent:► SubscribePatent Expiration:Aug 23, 2016Product Flag?Substance Flag?Delist Request?

Expired Orange Book Patents for NDA: 020692



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice
Healthtrust
UBS
Argus Health
Colorcon
Merck
Harvard Business School
US Army
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot